Traditional Chinese medicine composition for promoting wound healing or repairing skin injury and application
Through traditional Chinese medicine compositions of purpura, forsythia, silky flowers, dandelion, cypress and centipede, combined with auxiliary materials, they are prepared into ointment form, which solves the problems of long treatment time and adverse reactions in burn treatment, and significantly improves wound healing and skin The repair effect provides a safer and more effective treatment plan.
Patent Information
- Application Number
- CN202411250091.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-06
- Publication Date
- 2024-11-08
AI Technical Summary
The existing burn treatment methods have problems with long treatment time and adverse reactions, especially Western medicines such as silver sulfadiazine will cause neutropenia and nephrotoxicity during long-term use. Traditional Chinese medicine compositions have multiple components, multiple targets, and multiple The advantages of the effect, but the existing traditional Chinese medicine compound treatment drugs are insufficient in clearing heat and detoxifying, relieving pain, promoting wound healing and skin repair.
Provide a traditional Chinese medicine composition, including cypress, forsythia, cherry blossom, dandelion, cypress and centipede, prepared in the form of ointment by extraction method, combining auxiliary materials such as emulsifiers and preservatives to enhance their heat clearance, detoxification, relieve pain, and promote wounds. Healing and skin repair effects.
This traditional Chinese medicine composition significantly improves the wound healing rate and skin repair effect in burn treatment. Compared with existing traditional Chinese medicine compound treatment drugs, it has better ability to clear heat and detoxify, relieve pain, promote wound healing and skin repair, and reduce the occurrence of adverse reactions .
Smart Images

Figure CN118903287A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of traditional Chinese medicines, and in particular to a traditional Chinese medicine composition for promoting wound healing or repairing skin damage and its application. Background Art
[0002] Burns and scalds are the fourth most common type of trauma in the world. They are caused by the action of boiling water (oil), fire, light, electricity, radiation or chemical substances on the human body. According to statistics, 20 million people suffer from burns of varying degrees every year in my country, accounting for 1.5%-2.0% of the total population. Burns are often accompanied by problems such as wound inflammation and slow wound healing. Western medicine is widely used in the treatment of burns and scalds, but the treatment time is slightly longer and there are obvious adverse reactions. For example, long-term use of silver sulfadiazine can cause neutropenia and nephrotoxicity. Chinese medicine compositions have the effects of multiple components, multiple targets and multiple effects, and their drug resistance and adverse reactions are small, which has certain advantages.
[0003] Therefore, there is an urgent need to provide a Chinese medicine composition for burns that is safe and has healing-promoting and anti-inflammatory effects to meet market demand. Summary of the invention
[0004] In traditional Chinese medicine, heat-clearing, detoxifying and blood-cooling drugs are often used externally on local burn wounds to achieve therapeutic effects. Therefore, the present invention provides a group of new Chinese medicine compositions for treating burns and promoting wound healing or repairing skin damage, and a preparation method of the composition. Compared with the currently available Chinese medicine compound therapeutic drugs, the composition has better effects of clearing heat and detoxifying, clearing heat and cooling blood, relieving pain, promoting wound healing and skin repair.
[0005] On the one hand, the present application provides a traditional Chinese medicine composition for promoting wound healing or repairing skin damage. The traditional Chinese medicine composition comprises, by weight: 35-80 parts of Lithospermum officinale, 35-80 parts of Forsythia suspensa, 15-60 parts of Honeysuckle, 15-60 parts of Taraxacum officinale, 15-60 parts of Phellodendron chinense, 0.5-4 parts of Scolopendra subspinipes, and 1-30 parts of Borneol.
[0006] Furthermore, the Chinese medicine composition comprises, by weight: 40-70 parts of Lithospermum officinale, 40-70 parts of Forsythia suspensa, 20-50 parts of Honeysuckle, 20-50 parts of Taraxacum officinale, 20-50 parts of Phellodendron amurense, 1-4 parts of Scolopendra subspinipes, and 5-30 parts of Borneol.
[0007] Specifically, the lithospermum officinale can be selected from any value of 35 parts, 40 parts, 50 parts, 51 parts, 52 parts, 53 parts, 54 parts, 55 parts, 56 parts, 57 parts, 58 parts, 59 parts, 60 parts, 61 parts, 62 parts, 63 parts, 64 parts, 65 parts, 70 parts, 75 parts, and 80 parts.
[0008] The Forsythia suspensa can be selected from any value of 35 parts, 40 parts, 50 parts, 51 parts, 52 parts, 53 parts, 54 parts, 55 parts, 56 parts, 57 parts, 58 parts, 59 parts, 60 parts, 61 parts, 62 parts, 63 parts, 64 parts, 65 parts, 70 parts, 75 parts, and 80 parts.
[0009] The honeysuckle can be selected from any value of 15 parts, 20 parts, 30 parts, 31 parts, 32 parts, 33 parts, 34 parts, 35 parts, 36 parts, 37 parts, 38 parts, 39 parts, 40 parts, 41 parts, 42 parts, 43 parts, 44 parts, 45 parts, 50 parts, 55 parts, and 60 parts.
[0010] The dandelion can be selected from any value of 15, 20, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 50, 55, and 60 parts.
[0011] The Phellodendron chinense can be selected from any value of 15 parts, 20 parts, 30 parts, 31 parts, 32 parts, 33 parts, 34 parts, 35 parts, 36 parts, 37 parts, 38 parts, 39 parts, 40 parts, 41 parts, 42 parts, 43 parts, 44 parts, 45 parts, 50 parts, 55 parts, and 60 parts.
[0012] The centipede can be selected from any value among 0.5 parts, 1 parts, 1.5 parts, 2 parts, 2.4 parts, 2.5 parts, 3 parts, 3.5 parts, and 4 parts.
[0013] The borneol can be selected from any value of 1 part, 5 parts, 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, 15 parts, 16 parts, 17 parts, 18 parts, 19 parts, 20 parts, 25 parts, and 30 parts.
[0014] Furthermore, in terms of weight, the Chinese medicine composition includes: 60 parts of Lithospermum officinale, 60 parts of Forsythia suspensa, 40 parts of Honeysuckle Flos, 40 parts of Taraxacum officinale, 40 parts of Phellodendron amurense, 2.4 parts of Scolopendra subspinipes, and 15 parts of Borneol.
[0015] In a preferred embodiment, the traditional Chinese medicine composition comprises: 60g of Lithospermum officinale, 60g of Forsythia suspensa, 40g of Honeysuckle Flos, 40g of Taraxacum mongolicum, 40g of Phellodendron chinense, 2.4g of Scolopendra subspinipes, and 15g of Borneol.
[0016] The Chinese medicine composition for treating burns provided in the present application includes: lithospermum officinale, forsythia suspensa, honeysuckle, dandelion, phellodendron, centipede, and borneol. In the prescription, lithospermum officinale is sweet and salty in nature and cold in nature, and has the functions of cooling blood and activating blood circulation, detoxifying and clearing rashes, and is good at treating water and fire burns; forsythia suspensa is bitter in nature and cold in nature, and has the functions of clearing heat and detoxifying, reducing swelling and dispersing knots. Both medicines can clear heat and detoxify, evacuate wind-heat, and make the fire and heat toxic evil penetrate the surface, and they are reused as monarch medicines. Honeysuckle is sweet in nature and cold in nature, and has the functions of clearing heat and detoxifying, evacuating wind-heat; dandelion is sweet and slightly bitter in nature and cold in nature, and has the functions of clearing heat and detoxifying, reducing swelling and dispersing knots, and diuresis and relieving stranguria; phellodendron is bitter in nature and cold in nature, and has the functions of clearing heat and drying dampness, purging fire and detoxifying. The three medicines are used together to help lithospermum officinale and forsythia suspensa to clear heat and purge fire, cool blood and detoxify, and are all minister medicines. Borneol tastes spicy and has a cold nature. It has the functions of clearing heat and relieving pain, purging fire and detoxifying, and is used as an adjuvant. Centipede has the functions of calming wind and relieving spasm, attacking toxins and dispersing knots, and dredge meridians and relieve pain. It can enhance the analgesic effect when combined with borneol, and is also used as an adjuvant. The combination of these medicines can play the role of clearing heat and detoxifying, reducing swelling and relieving pain, and promoting blood circulation and promoting muscle regeneration.
[0017] It is understood by those skilled in the art that the composition of the present application may further include excipients. The excipients may be appropriate solvents, propellants, solubilizers, cosolvents, emulsifiers, colorants, adhesives, disintegrants, fillers, lubricants, wetting agents, osmotic pressure regulators, stabilizers, glidants, flavoring agents, preservatives, suspending agents, coating materials, aromatics, anti-adhesive agents, integrators, penetration enhancers, pH regulators, buffers, plasticizers, surfactants, foaming agents, defoamers, thickeners, inclusion agents, humectants, absorbents, diluents, flocculants and deflocculating agents, filter aids, release retardants, etc., which can make the Chinese medicine composition of the present application have better physical stability or be prepared into a desired dosage form without affecting the efficacy of the effective ingredients of the Chinese medicine composition.
[0018] The dosage forms include ointments, liniments, creams, paints, gels, film coatings, gel patches or lotions, etc.
[0019] Optionally, the moisturizer includes but is not limited to at least one of glycerol, propylene glycol, 1,3-butylene glycol, sorbitol, polyethylene glycol, sodium pyrrolidone carboxylate, hyaluronic acid, lactic acid and sodium lactate. The disinfectant includes but is not limited to at least one of triclosan, parachloro-meta-xylenol, chlorhexidine acetate and polyhexamethylene biguanide.
[0020] Optionally, the pH adjuster includes but is not limited to at least one of boric acid, borax, sodium hydroxide, hydrochloric acid, phosphoric acid / phosphate buffer, acetic acid / acetate buffer, citric acid / citrate buffer, and boric acid / borate buffer.
[0021] Optionally, the preservative includes but is not limited to at least one of sodium benzoate, potassium benzoate, ethanol, sorbic acid, potassium sorbate, propylene glycol, glycerol, isopropyl alcohol or sodium propionate.
[0022] Optionally, the antioxidant includes but is not limited to at least one of sulfite, ascorbic acid, sodium pyrosulfite, glycine, cysteine, ascorbic acid, and sodium thiosulfate.
[0023] Preferably, the matrix includes but is not limited to at least one of a gel skeleton material, an oil phase matrix, and an emulsifier.
[0024] Optionally, the gel skeleton material includes but is not limited to at least one of a carbomer series, a cellulose derivative, and a chitosan matrix.
[0025] The oil phase matrix includes but is not limited to at least one of vegetable oil, higher fatty alcohol, beeswax, stearic acid, lanolin, vaseline, stearyl alcohol, and paraffin.
[0026] Optionally, the selected emulsifier includes but is not limited to at least one of Tween, Span, triethylamine, and stearyl glyceryl.
[0027] Preferably, the carrier includes but is not limited to one or more of an excipient, an antioxidant, a pH adjuster, a preservative, and a flavoring agent.
[0028] Optionally, the excipient includes but is not limited to at least one of mannitol, sorbitol, glucose, sodium chloride, lactose, starch, dextran, cyclodextrin or a cyclodextrin derivative.
[0029] In some specific embodiments, the dosage form of the external preparation is an ointment, and the external preparation comprises the above-mentioned traditional Chinese medicine composition, and excipients and emulsifiers. The external preparation is prepared by the following method:
[0030] Take the oil phase matrix and the water phase auxiliary material, heat them to 70-90°C, and after they are completely melted, add the Chinese medicine composition powder and mix well to obtain the product.
[0031] In some specific embodiments, the dosage form of the external preparation is an ointment, and the external preparation comprises the above-mentioned traditional Chinese medicine composition, and excipients and emulsifiers. The external preparation is prepared by the following method:
[0032] Take the oil phase auxiliary materials and emulsifier, heat them to 70-90°C, and after they are completely melted, add the lithospermum extract, and mix them to obtain the oil phase; take the water phase auxiliary materials and emulsifier, heat them to 70-90°C, and after they are completely melted, add the extracts obtained by extracting forsythia, honeysuckle, dandelion, phellodendron and centipede to obtain the water phase; at 70-90°C, slowly add the water phase into the oil phase, stir, cool, add borneol powder, stir evenly, and obtain.
[0033] Preferably, the oil phase auxiliary material includes but is not limited to at least one of stearic acid, glyceryl stearate, lanolin, vaseline, stearyl alcohol, paraffin, beeswax, and vegetable oil; the amount of the oil phase auxiliary material is 0.25-1.5 times the mass of the traditional Chinese medicine composition.
[0034] Preferably, the aqueous phase auxiliary material includes but is not limited to at least one of glycerol, sorbitol, water, propylene glycol, and polyethylene glycol; the amount of the aqueous phase auxiliary material is 0.15-0.75 times the mass of the traditional Chinese medicine composition.
[0035] Preferably, the emulsifier includes but is not limited to at least one of Tween, Span and triethylamine; the amount of the emulsifier is 0.03-0.5 times the mass of the traditional Chinese medicine composition.
[0036] On the other hand, the present application also provides a method for preparing the Chinese medicine composition, the method comprising the following steps:
[0037] Step 1, soaking Lithospermum officinale with a first extractant, heating and extracting, to obtain a first extract; the first extractant is alcohol or oil;
[0038] Step 2, soaking the forsythia, honeysuckle, dandelion, phellodendron, and centipede in a second extractant, heating and extracting, and obtaining a second extract;
[0039] Step 3: Crush the borneol to obtain borneol powder, and mix the borneol powder with the first extract and the second extract to obtain a traditional Chinese medicine composition.
[0040] Furthermore, the oil is sesame oil; preferably, the solid-liquid ratio of the lithospermum officinale to sesame oil is 1:(5-8); preferably, the soaking time is 20-40 minutes; preferably, the heating extraction temperature is 140°C-160°C, and the heating time is 5-20 minutes.
[0041] The solid-liquid ratio of lithospermum officinale to sesame oil is any value among 1:5, 1:6, 1:7 and 1:8.
[0042] The soaking time is any value among 20 minutes, 30 minutes and 40 minutes.
[0043] The heating extraction temperature is any one of 140°C, 145°C, 150°C, 155°C, and 160°C.
[0044] The heating time is any one of 5 minutes, 6 minutes, 7 minutes, 8 minutes, 9 minutes, 10 minutes, 11 minutes, 12 minutes, 13 minutes, 14 minutes, 15 minutes, 16 minutes, 17 minutes, 18 minutes, 19 minutes, and 20 minutes.
[0045] Further, the alcohol is ethanol; preferably, the concentration of the ethanol is 60%-80%; preferably, in the step 1, ethanol is used to soak the lithospermum for 20-40 minutes; more preferably, the solid-liquid ratio of lithospermum to ethanol in the step 1 is 1:(8-14); more preferably, the solid-liquid ratio of lithospermum to ethanol in the step 1 is 1:(10-12);
[0046] Preferably, the heating extraction is heating reflux; more preferably, in the step 1, the first extractant is used as the heating reflux extractant and the heating reflux is performed 2-3 times, each time for 0.5-2 hours.
[0047] The concentration of ethanol is any one of 60%, 70% and 80%.
[0048] Preferably, the concentration of the ethanol is 70%.
[0049] In the step 1, the time for soaking Lithospermum officinale in ethanol can be any value among 20 minutes, 30 minutes and 40 minutes.
[0050] In the step 1, the material-liquid ratio of lithospermum officinale to ethanol can be any value among 1:8, 1:9, 1:10, 1:11, 1:12, 1:13, and 1:14.
[0051] In the step 1, the first extractant is used as the heating reflux extractant and is heated and refluxed for 2 or 3 times.
[0052] The heating reflux time can be any value among 0.5 hours, 1 hour, 1.5 hours and 2 hours.
[0053] Furthermore, in the step 1, the first extractant is used as the heating reflux extractant and the heating reflux is performed twice.
[0054] Preferably, the first time the first extractant is used as the extractant for heating and reflux for 1.5 hours, and the second time the first extractant is used as the extractant for heating and reflux for 1 hour.
[0055] Those skilled in the art can heat and reflux the traditional Chinese medicine in a common manner.
[0056] In a preferred embodiment, the temperature of the heating extraction in step 1 is 70°C-90°C.
[0057] The heating extraction temperature can be any value among 70°C, 80°C and 90°C.
[0058] Furthermore, the second extracting agent is water; preferably, in the step 2, the soaking time of Forsythia suspensa, honeysuckle, dandelion, Phellodendron chinense, and Scolopides scolopendra in the second extracting agent is 0.5-1.5 hours; preferably, in the step 1, the solid-liquid ratio of Forsythia suspensa, honeysuckle, dandelion, Phellodendron chinense, and Scolopides scolopendra to water is 1:(6-10).
[0059] Wherein, in the step 2, the soaking time of Forsythia suspensa, honeysuckle, dandelion, Phellodendron chinense and Scolopendra subspinipes in the second extractant is any value among 0.5 hours, 1 hour and 1.5 hours.
[0060] In the step 1, the material-liquid ratio of Forsythia suspensa, Honeysuckle Flos, Taraxacum officinale, Phellodendron amurense, Scolopendra subspinipes to water is any value among 1:6, 1:7, 1:8, 1:9, and 1:10.
[0061] Furthermore, the heating extraction in step 2 is performed by heating and reflux with the second extractant as the extractant for 2-3 times, each time for 0.5-3 hours.
[0062] Wherein, the heating extraction in step 2 is performed by heating and reflux with the second extractant as the extractant for 2 or 3 times, each time for 0.5 hour, 1 hour, 1.5 hours, 2 hours, 2.5 hours or 3 hours.
[0063] In a preferred embodiment, the heating extraction in step 2 is performed by heating and reflux twice with the second extractant as the extractant, the first time for 2.5 hours and the second time for 2 hours.
[0064] In a preferred embodiment, the heating extraction in step 2 is performed by heating and reflux with the second extractant as the extractant for 3 times, the first time for 1.5 hours, the second time for 1 hour, and the third time for 1 hour.
[0065] Those skilled in the art can heat and reflux the traditional Chinese medicine in a common manner.
[0066] In a preferred embodiment, the temperature of the heating extraction in step 2 is 75°C-100°C.
[0067] The heating extraction temperature can be any value among 75°C, 80°C, 85°C, 90°C, 95°C, and 100°C.
[0068] Furthermore, the step 2 also includes an alcohol precipitation step, wherein the alcohol precipitation is to combine the extracts after heating and refluxing and concentrate them into a clear paste, and ethanol is added to the clear paste to make the alcohol content reach 60%-80%; more preferably, 70%.
[0069] On the other hand, the present application also provides a product comprising the Chinese medicine composition.
[0070] Preferably, the dosage form of the product is a paste.
[0071] More preferably, the product further comprises lanolin, polyethylene glycol, glyceryl stearate and / or Tween 80.
[0072] In a preferred embodiment, the preparation method of the Chinese medicine composition comprises the following steps:
[0073] (1) According to the prescription amount, 60%-80% ethanol is added to lithospermum for soaking for 20-40 minutes, the solid-liquid ratio of lithospermum to 60%-80% ethanol is 1:(10-12), 60%-80% ethanol is added and heated to reflux 2-3 times, the heating reflux temperature is 70°C-90°C, each time for 0.5-2 hours, the extracts are combined, and the extracts are concentrated under reduced pressure at 60°C-80°C until there is no alcohol taste, and dried under reduced pressure at 60°C-80°C to prepare lithospermum extract;
[0074] (2) Soaking forsythia, honeysuckle, dandelion, phellodendron and centipede in water for 0.5-1.5 hours with a solid-liquid ratio of 1:(6-10), heating and reflux extraction 2-3 times, heating and reflux temperature 75°C-100°C, each time for 0.5-3 hours, combining the extracts, concentrating under reduced pressure at 60°C-80°C, and drying under reduced pressure at 60°C-80°C to prepare a dry paste powder;
[0075] (3) crushing borneol into fine powder to obtain borneol powder;
[0076] (4) Evenly mix the borneol powder obtained in (3), the dry paste powder obtained in (2), and the lithospermum officinale extract obtained in (1) to obtain a traditional Chinese medicine composition.
[0077] In a preferred embodiment, the Chinese medicine composition can be prepared into an ointment, specifically comprising: stirring and melting lanolin and polyethylene glycol at 70° C.-90° C., adding the Chinese medicine composition, and cooling after dissolving.
[0078] In a preferred embodiment, the preparation method of the Chinese medicine composition comprises the following steps:
[0079] (1) according to the prescription amount, lithospermum officinale and sesame oil are soaked for 20-40 minutes, the solid-liquid ratio is 1: (5-8), heated to 140° C.-160° C., extracted for 5-20 minutes, and obtained lithospermum officinale extract;
[0080] (2) Soaking forsythia, honeysuckle, dandelion, phellodendron and centipede in water for 0.5-1.5 hours with a solid-liquid ratio of 1:(6-10), heating and reflux extraction 2-3 times, heating and reflux temperature 75°C-100°C, each time for 0.5-3 hours, combining the extracts, and concentrating to a clear paste with a density of 1.06-1.10;
[0081] (3) crushing borneol into fine powder to obtain borneol powder;
[0082] (4) Evenly mix the borneol powder obtained in (3), the dry paste powder obtained in (2), and the lithospermum officinale extract obtained in (1) to obtain a traditional Chinese medicine composition.
[0083] In a preferred embodiment, lanolin and stearin are heated to 70-90°C, and after they are completely melted, lithospermum extract is added, and the oil phase is obtained after mixing; polyethylene glycol and Tween 80 are heated to 70-90°C, and after they are completely melted, extracts obtained by extracting Forsythia suspensa, honeysuckle, dandelion, Phellodendron chinense and Scolopendra subspinipes are added to obtain the water phase; at 70-90°C, the water phase is slowly added to the oil phase, stirred, cooled, borneol powder is added, and stirred evenly to obtain the product.
[0084] In a preferred embodiment, the step (2) further comprises an alcohol precipitation step, wherein the alcohol precipitation is to combine the extracts after heating and refluxing and concentrate them into a clear paste, and ethanol is added to the clear paste to make the alcohol content reach 60%-80%.
[0085] On the other hand, the present application also provides the use of the traditional Chinese medicine composition, the preparation method or the product in the preparation of a drug for promoting wound healing or a drug for repairing skin damage.
[0086] On the other hand, the present application also provides the use of the traditional Chinese medicine composition, the preparation method or the product in the preparation of medicines for treating burns.
[0087] The present invention has the following beneficial effects:
[0088] The present invention provides a group of new Chinese medicine compositions for treating burns and promoting wound healing or repairing skin damage. Compared with the currently available Chinese medicine compound therapeutic drugs, the compositions have better effects of clearing away heat and detoxifying, clearing heat and cooling blood, relieving pain, promoting wound healing and repairing skin. BRIEF DESCRIPTION OF THE DRAWINGS
[0089] The drawings described herein are used to provide a further understanding of the present application and constitute a part of the present application. The illustrative embodiments of the present application and their descriptions are used to explain the present application and do not constitute an improper limitation on the present application. In the drawings:
[0090] Figure 1 The typical pictures of skin pathology of burns in each group of Example 1, wherein A: model control group; B: positive control group; C: (lithospermum water extract sample group) test example 1; D: (lithospermum oil extract sample group) test example 3; E: (lithospermum alcohol extract sample group) test example 2;
[0091] Figure 2 This is a schematic diagram showing the comparison of rat skin scald treatment before and after treatment in Example 2;
[0092] Figure 3 This is a typical picture of the skin pathology of burns in Example 2. DETAILED DESCRIPTION
[0093] In order to more clearly explain the overall concept of the present application, the following is described in detail in conjunction with the accompanying drawings of the specification by way of embodiment. In the following description, a large number of specific details are provided to provide a more thorough understanding of the present invention. However, it is obvious to those skilled in the art that the present invention can be implemented without one or more of these details. In other examples, in order to avoid confusion with the present invention, some technical features well known in the art are not described.
[0094] If no specific conditions are specified in the examples, the experiments were carried out according to conventional conditions or conditions recommended by the manufacturer.
[0095] Unless otherwise specified, in the following embodiments, the reagents or instruments used without indicating the manufacturer are all conventional products that can be purchased commercially.
[0096] Among them, compound phellodendron liquid coating, moist burn ointment It is a commercially available product.
[0097] Example 1
[0098] Test Example 1
[0099] Chinese medicine composition: 60g of Lithospermum officinale, 60g of Forsythia suspensa, 40g of Honeysuckle Flos, 40g of Taraxacum mongolicum, 40g of Phellodendron chinense, 2.4g of Scolopendra subspinipes, and 15g of Borneol.
[0100] The preparation method of the Chinese medicine composition comprises the following steps:
[0101] (1) Soaking lithospermum officinale, forsythia suspensa, honeysuckle, dandelion, phellodendron chinense and centipede in water for 30 minutes, with a solid-liquid ratio of 1:8, and heating and reflux at 100° C. for 2 times; during the first reflux extraction, the reflux time is 2.5 hours; during the second reflux extraction, the reflux time is 2 hours, the extracts are combined, filtered, and the filtrate is concentrated under reduced pressure to 8 times at 70° C. to prepare a clear paste, ethanol is added to make the alcohol content reach 70%, and then filtered after standing for 24 hours. The filtrate is concentrated under reduced pressure at 70° C. until there is no alcohol taste, filtered, and the clear paste is dried under reduced pressure at 60° C. to prepare a dry paste powder;
[0102] (2) crushing borneol into fine powder, and mixing it with the dry paste powder obtained in step (1) to obtain powder;
[0103] (3) Take 200 g of lanolin and 100 g of polyethylene glycol 6000, melt them at 80° C., add the powder obtained in step (2) and mix well. After all the lanolin is dissolved, cool to room temperature to obtain a Chinese medicine composition.
[0104] Test Example 2
[0105] Chinese medicine composition: 60g of Lithospermum officinale, 60g of Forsythia suspensa, 40g of Honeysuckle Flos, 40g of Taraxacum mongolicum, 40g of Phellodendron chinense, 2.4g of Scolopendra subspinipes, and 15g of Borneol.
[0106] The preparation method of the Chinese medicine composition comprises the following steps:
[0107] (1) According to the prescription amount, lithospermum officinale is soaked in 70% ethanol for 30 minutes, with a solid-liquid ratio of 1:12, and heated to reflux twice at 80°C, with the first reflux time being 1.5 hours and the second reflux time being 1 hour. The extracts are combined and filtered, and the filtrate is concentrated under reduced pressure at 70°C until there is no alcohol taste, and the clear paste is dried under reduced pressure at 60°C to prepare lithospermum officinale extract;
[0108] (2) Forsythia suspensa, honeysuckle, dandelion, phellodendron chinense and centipede were soaked in water for 1 hour, with a solid-liquid ratio of 1:8, and heated to reflux twice at 100°C; during the first reflux extraction, the reflux time was 2.5 hours; during the second reflux extraction, the reflux time was 2 hours; the extracts were combined, filtered, and the filtrate was concentrated to 8 times under reduced pressure at 70°C to prepare a clear paste, ethanol was added to make the alcohol content reach 70%, and then filtered after standing for 24 hours. The filtrate was concentrated under reduced pressure at 70°C until there was no alcohol taste, filtered, and the clear paste was dried under reduced pressure at 60°C to prepare a dry paste powder;
[0109] (3) crushing borneol into fine powder, and mixing it with the lithospermum officinale extract in step (1) and the dry paste powder in step (2) to obtain a powder;
[0110] (4) Take 200 g of lanolin and 100 g of polyethylene glycol 6000, melt them at 80° C., add the powder obtained in step (3) and mix well. After all the lanolin is dissolved, cool to room temperature to obtain a Chinese medicine composition.
[0111] Test Example 3
[0112] Chinese medicine composition: 60g of Lithospermum officinale, 60g of Forsythia suspensa, 40g of Honeysuckle Flos, 40g of Taraxacum mongolicum, 40g of Phellodendron chinense, 2.4g of Scolopendra subspinipes, and 15g of Borneol.
[0113] The preparation method of the Chinese medicine composition comprises the following steps:
[0114] (1) According to the prescribed amount, lithospermum officinale and sesame oil were soaked for 30 minutes, with a solid-liquid ratio of 1:6, heated to 150° C., extracted for 10 minutes, and filtered to obtain lithospermum officinale extract;
[0115] (2) Forsythia suspensa, honeysuckle, dandelion, Phellodendron chinense and Scolopendra subspinipes were soaked in water for 1 hour with a solid-liquid ratio of 1:8, and heated under reflux for 3 times at 100°C; the first heating reflux extraction was 1.5 hours, the second heating reflux extraction was 1 hour, and the third heating reflux extraction was 1 hour; the extracts were combined, filtered, and the filtrate was concentrated to a clear paste with a relative density of about 1.08 (60°C), ethanol was added to make the alcohol content reach 70%, and the mixture was allowed to stand for 24 hours, filtered, and the ethanol was recovered until there was no alcohol taste to obtain a concentrated solution;
[0116] (3) Crush borneol into fine powder;
[0117] (4) Take 200g of lanolin and 15g of stearic acid glyceryl, heat them to 80°C, and add lithospermum extract after they are completely melted, and mix them to obtain the oil phase; take 100g of polyethylene glycol 6000 and 50g of Tween 80, heat them to 80°C, and add the concentrate after they are completely melted to obtain the water phase; at 80°C, slowly add the water phase to the oil phase, stir, cool, add borneol powder, and stir evenly to obtain the Chinese medicine composition.
[0118] Burn and scald drug efficacy screening test:
[0119] In this example, test examples 1-3 are used as samples to explore the effects of different extraction methods on the efficacy of the Chinese medicine composition. The specific test method is as follows:
[0120] Fifty rats were randomly divided into five groups according to their body weight: model control group, positive control group, test example 1, test example 2, and test example 3, with 10 rats in each group. After anesthesia, the rats in each group were placed with their backs facing up, and the hair on both sides of the back to be scalded was shaved, and the short hair was removed with a depilatory agent to expose the skin. A scalding surface was set on each side of the back of the rat's hind limbs. The scalding head (diameter 2.2 cm) of the scalding instrument was set to pressure: 0.5 kg; temperature: 100 ° C, time 15 s. After the temperature stabilized, the marked part of the rat's back was scalded to prepare a rat deep II degree scald model.
[0121] Each group was given the corresponding topical ointment or liquefied substance immediately after scalding, which was applied to the wound surface with a thickness of less than 1 mm, 3 times a day, and continued to be administered for 20 days. The wound healing of the rats was monitored every 2-3 days, and the area on the first day was used as the benchmark. The wound healing of each group was monitored by taking pictures, and the wound area was analyzed by Image J software, and the wound healing rate was calculated. The results of the wound healing rate are shown in Table 1.
[0122] Wound healing rate (%) = (wound area before administration - wound area after administration) / wound area before administration × 100%.
[0123] After 20 days of continuous administration, the burn wound and the surrounding skin were removed and fixed in 10% formalin. The skin with a width of about 3-4 mm was cut and paraffin sections were prepared according to routine procedures. The sections were stained with hematoxylin-eosin (HE), observed under a microscope and photographed. Figure 1 shown.
[0124] Pathological diagnosis was based on the semi-quantitative standardized evaluation method of the histopathology of the skin wound healing model: each pathological section observed the skin structure, epithelial regeneration, granulation tissue, neutrophils, macrophages, collagen fiber distribution, vascular endothelial cell density and other indicators (collagen fiber distribution and vascular endothelial cell density indicators need to be combined with Masson staining and CD31 immunohistochemical specimen staining, respectively), and the above indicators were evaluated for the main indicators of wound healing (horizontally) and wound healing stage evaluation (vertically). The specific scores of the semi-quantitative standardized evaluation system of the histopathology of the skin wound healing model are shown in Tables 2 and 3, and the results are shown in Tables 4 and 5.
[0125] All the above data are expressed as Mean ± SD, and SPSS16.0 software was used for statistical analysis. Measurement data were analyzed by one-way analysis of variance (ANOVA) or T test. If the variance of measurement data was equal, one-way analysis of variance LSD test was used. If the variance of measurement data was unequal, one-way analysis of variance Dunnett's T3 test was used.
[0126] Table 1 Statistical results of wound healing rate in rats (%, Mean ± SD)
[0127]
[0128]
[0129] Note: #Compared with model control group, P<0.05; &Compared with positive control group, P<0.05.
[0130] The results in Table 1 show that compared with the model control group, the wound healing rates of the sample group of Experimental Example 1 were higher than those of the model control group at 6d and 9d after modeling, the wound healing rates of the sample group of Experimental Example 2 were higher than those of the model control group at 6d, 9d, 13d, and 16d after modeling, and the wound healing rates of the sample group of Experimental Example 3 were always higher than those of the model control group at 6d, 9d, 13d, 16d, and 20d after modeling, and the differences were statistically significant (P<0.05); compared with the positive control group, the wound healing rates of the sample groups of Experimental Example 1 and Experimental Example 2 were higher than those of the positive control group at 6d after modeling, and the wound healing rates of the sample group of Experimental Example 3 were higher than those of the positive control group at 6d, 13d, 16d, and 20d after modeling, and the differences were statistically significant (P<0.05). By the end of the experiment, the epidermis of the burn wounds of the rats in the sample group of Experimental Example 3 had completely healed by naked eye observation.
[0131] The above results show that the samples extracted from Experimental Examples 1-3 can promote the healing of deep second-degree burn model wounds in rats by naked eye observation of epidermal wounds.
[0132] Table 2 Semi-quantitative evaluation of main indicators of wound healing (horizontal)
[0133]
[0134] Table 3 Stage evaluation of wound healing (longitudinal)
[0135]
[0136] Table 4 Semi-quantitative evaluation table of main indicators of skin burn healing in rats (horizontal, Mean ± SD)
[0137]
[0138] Note: #Compared with model control group, P<0.05; &Compared with positive control group, P<0.05.
[0139] Table 5 Evaluation table of the healing stages of skin burns in rats (vertical)
[0140]
[0141] Depend on Figure 1 The results showed that after continuous administration of the drug to the scalded area of rats for 20 days, the skin tissue of the burn area was observed under a HE staining microscope after dissection. It was found that the skin wounds in each group were basically covered by new epidermis, and granulation tissue and inflammatory cell infiltration were visible in the superficial dermis; in some cases, epithelial hyperplasia was incomplete, and scabs formed by exudates were visible on the surface, with epidermal necrotic layer attached.
[0142] The results of the horizontal main index scores in Table 4 show that compared with the model control group, the epithelial regeneration scores of the sample groups of Experimental Example 3 and Experimental Example 2 were significantly higher than those of the model control group, and the difference was statistically significant (P<0.05). Except for the macrophage index of the sample group of Experimental Example 2, which was higher than that of the model control group, the granulation tissue and neutrophil indexes of each test sample group had no significant differences with those of the model control group (P>0.05).
[0143] The longitudinal healing stage scoring results in Table 5 show that there is no significant difference in the scores of each group. Most skin tissues are in the middle stage of healing and hyperplasia, among which some cases in the positive control group and the sample groups of Experimental Examples 2 and 3 have reached the late stage of healing and hyperplasia.
[0144] The above results show that the samples of Experimental Examples 2 and 3 have the effect of promoting the repair of skin tissue damage in the rat deep second-degree burn model by pathological observation of skin tissue under the microscope.
[0145] Based on the above tests, the samples of Test Example 1, Test Example 2, and Test Example 3 applied to rats after deep second-degree burn modeling all had a healing effect on the epidermal wound surface (Test Example 3> Test Example 2> Test Example 1), and the effect was better than that of moist burn ointment. At the same time, pathological histological examination showed that Test Example 3 and Test Example 2 had a repairing effect on the skin damage at the burn site.
[0146] Example 2
[0147] Based on the preferred extraction method in Example 1 (Test Example 2 and Test Example 3), this example continues to explore the influence of the composition components on its effects.
[0148] Test Example 4
[0149] Another Chinese medicine composition for promoting wound healing or repairing skin damage comprises the following raw materials:
[0150] 40g of Lithospermum officinale, 40g of Forsythia suspensa, 20g of Honeysuckle, 20g of Phellodendron chinense, 20g of Taraxacum mongolicum, 5g of Borneolum, and 1g of Centipede.
[0151] The preparation method of the Chinese medicine composition is the same as that of Experimental Example 2.
[0152] Test Example 5
[0153] Another Chinese medicine composition for promoting wound healing or repairing skin damage comprises the following raw materials:
[0154] 80g of Lithospermum officinale, 80g of Forsythia suspensa, 60g of Honeysuckle, 60g of Phellodendron chinense, 60g of Taraxacum mongolicum, 25g of Borneolum, and 4.0g of Centipede.
[0155] The preparation method of the Chinese medicine composition is the same as that of Experimental Example 2.
[0156] Test Example 6
[0157] Another Chinese medicine composition for promoting wound healing or repairing skin damage comprises the following raw materials:
[0158] 40g of Lithospermum officinale, 40g of Forsythia suspensa, 20g of Honeysuckle, 20g of Phellodendron chinense, 20g of Taraxacum mongolicum, 5g of Borneolum, and 1g of Centipede.
[0159] The preparation method of the Chinese medicine composition is the same as that of Experimental Example 3.
[0160] Test Example 7
[0161] Another Chinese medicine composition for promoting wound healing or repairing skin damage comprises the following raw materials:
[0162] 80g of Lithospermum officinale, 80g of Forsythia suspensa, 60g of Honeysuckle, 60g of Phellodendron chinense, 60g of Taraxacum mongolicum, 25g of Borneolum, and 4.0g of Centipede.
[0163] The preparation method of the Chinese medicine composition is the same as that of Experimental Example 3.
[0164] Test Example 8
[0165] Another Chinese medicine composition for treating burns is different from Experimental Example 2 only in that in this Experimental Example, Flos Lonicerae is replaced with an equal amount of Flos Honeysuckle, and the other components remain unchanged.
[0166] Test Example 9
[0167] Another Chinese medicine composition for treating burns is different from Experimental Example 3 only in that in this Experimental Example, honeysuckle flowers are replaced with an equal amount of honeysuckle flowers, and the other components remain unchanged.
[0168] Test Example 10
[0169] Another Chinese medicine composition for treating burns is different from Experimental Example 3 only in that Lithospermum officinale and Borneol are not added in this Experimental Example, and the other components remain unchanged.
[0170] Comparative Example 1
[0171] Compound Phellodendron liquid paint.
[0172] Burn and scald drug efficacy screening test
[0173] In this test example, the Chinese medicine composition prepared by the method of Test Examples 3-10 and Comparative Example 1 was used as a sample to conduct a burn and scald efficacy screening test. The specific test method is as follows:
[0174] Rats were randomly divided into 12 groups according to their body weight: normal control group, model control group, positive control group, test examples 3-10 and comparative example 1 sample group, among which 11 rats were not treated as blank control group, 12 rats were used as model control group, and the remaining animals were 11 in each group. Rats in each group were anesthetized 24 hours before modeling, with their backs facing up, and the parts to be scalded on both sides of the back were shaved, and the short hair was removed with a depilatory to expose the skin. On the day of modeling, except for the normal control group, other rats were anesthetized, and a scalding surface was set on each side of the back of the depilatory part. The scalding head (diameter 2.0 cm) of the scalding instrument was set to pressure: 0.5 kg; temperature: 75°C, time 10s, and after the temperature stabilized, the marked parts of the rats' backs were scalded to prepare a rat deep II degree scald model. The classification of burns and scald grades is shown in Table 6.
[0175] Each group was given the corresponding topical ointment or liquefied substance immediately after scalding, applied to the wound surface, 0.2 mL / scalded surface / time, twice a day, with an interval of no less than 5 hours, for 7 consecutive days, with a thickness of less than 1 mm, and the days of administration were marked as TD in the original records, the first day of administration was TD1, and so on. The normal control group and the model control group were applied with 0.9% sodium chloride injection in the same way, and the animals in each modeling group were kept in a single cage.
[0176] During the trial, the right wound surface was photographed before the first administration of TD1, before the first administration of TD4, and before autopsy (the results are shown in Figure 2 ), the wound area was analyzed using Image J software, and the wound healing rate was calculated. The results of wound healing rate are shown in Table 7.
[0177] Wound healing rate (%) = (TD1 wound area - TDn wound area) / TD1 wound area × 100%.
[0178] About 16 hours after the last drug administration, the animals were anesthetized and the skin on the right side of the animals was cut and placed in 10% formaldehyde fixative for histopathological examination. Each skin sample was cut longitudinally at the longest diameter of the wound surface, paraffin sections were prepared according to routine procedures, stained with hematoxylin-eosin (HE), observed under a microscope and photographed. The results are shown in the figure. Figure 3 shown.
[0179] Pathological diagnosis was based on the semi-quantitative standardized evaluation method of skin wound histopathology: each pathological section observed indicators such as skin structure, epithelial regeneration, granulation tissue, neutrophils, macrophages, etc., and the above indicators were analyzed for the evaluation of the main indicators of wound healing. The specific scores of the semi-quantitative standardized evaluation system of histopathology for skin wound healing model are shown in Table 8, and the results are shown in Table 9.
[0180] All the above data are expressed as Mean ± SD, and SPSS19 software was used for statistical analysis. Levene's test was used to detect the homogeneity of variance. If the variance was homogeneous (P>0.05), one-way analysis of variance (ANOVA) was performed. When there was a statistical difference (P≤0.05), Dunnett T test was used to compare the differences in components; if the variance was unequal (P≤0.05), Kruskal-Wallis test was performed. When the difference was statistically significant (P≤0.05), Mann-Whitney U rank sum test (MW method) was used to compare the differences between groups. The comparison of component differences was performed between the model control group, the positive control group (MEBO control group), and each group of test examples 3-10 and comparative example 1. All tests were two-sided tests with α=0.05.
[0181] Table 6
[0182]
[0183] Table 7 Summary of wound surface data (Mean±SD)
[0184]
[0185] Note: *P<0.05, **P<0.01, each group was compared with the model control group.
[0186] From the results in Table 7 and the wound surface observation results ( Figure 2 )visible,
[0187] Normal control group: The skin surface of the animals was smooth, flesh-pink, without wounds or scabs.
[0188] Model control group: Before administration of TD1, the skin of the animal modeling site was white, and all wounds were scabby from TD2 until the end of administration. All wound scabs of this group of animals did not fall off, and only 11 animals had the edges of wound scabs lifted.
[0189] MEBO control group: Before administration of TD1, the skin of the animal modeling site was white, and all the wounds were scab-formed from TD2 until the end of administration. The scabs of 3 animals in this group partially fell off, and the scabs of 1 animal fell off completely. New skin was seen growing at the sites where the scabs fell off.
[0190] Test Example Group 3: Before administration of TD1, the skin of the animal modeling site was white, and from TD2 onwards, all wounds were scabby. Until the end of administration, the scabs of 3 animals in this group partially fell off, and the scabs of 2 animals completely fell off. New skin was seen growing at the sites where the scabs fell off.
[0191] Test Example 4 Group: Before administration of TD1, the skin of the animal modeling site was white, and from TD2 onwards, all wounds were scabby until the end of administration. The scabs of 2 animals in this group partially fell off, and the scabs of 1 animal fell off completely. New skin was seen growing at the site where the scabs fell off.
[0192] Test Example 5 Group: Before administration of TD1, the skin of the animal modeling site was white, and from TD2 onwards, all wounds were scabby until the end of administration. The scabs of 4 animals in this group partially fell off, and new skin was seen growing at the site where the scabs fell off.
[0193] Test Example 6 Group: Before administration of TD1, the skin of the animal modeling site was white, and from TD2 onwards, all wounds were scabby until the end of administration. The scabs of 5 animals in this group partially fell off, and new skin was seen growing at the site where the scabs fell off.
[0194] Test Example 7 Group: Before administration of TD1, the skin of the animal modeling site was white, and from TD2 onwards, all wounds were scabby until the end of administration. The scab of one animal in this group partially fell off, and new skin was seen growing at the site where the scab fell off.
[0195] Test Example Group 8: Before administration of TD1, the skin of the animal modeling site was white, and all the wounds were scab-formed from TD2 until the end of administration. The scabs of one animal in this group partially fell off, and the scabs of one animal completely fell off. New skin was seen growing at the site where the scabs fell off.
[0196] Test Example 9 Group: Before administration of TD1, the skin of the animal modeling site was white, and all the wounds were scabby from TD2 until the end of administration. The scabs of 4 animals in this group partially fell off, and the scabs of 2 animals completely fell off. New skin was seen growing at the sites where the scabs fell off.
[0197] Test Example 10 Group: Before administration of TD1, the skin of the animal modeling site was white, and from TD2 onwards, all wounds were scabby until the end of administration. The scabs of 2 animals in this group partially fell off, and new skin was seen growing at the site where the scabs fell off.
[0198] Comparative Example Group 1: Before administration of TD1, the skin of the animal modeling site was white, and all wounds were scab-formed from TD2 until the end of administration. The scab of one animal in this group partially fell off, and new skin was seen growing at the site where the scab fell off.
[0199] The results of wound area measurement showed that at TD4 days, the wound area and wound healing rate of animals in the positive control group and test groups showed an improvement trend compared with the model control group (P>0.05); at TD8 days, the wound healing rates of the positive control group and test groups 6 and 9 were significantly higher than those of the model control group (P<0.05 or P<0.01).
[0200] Table 8 Histopathological scoring criteria
[0201]
[0202] Table 9 Histopathological scores (Mean±SD)
[0203]
[0204]
[0205] Note: *P<0.05, **P<0.01, each group compared with model control group; #P<0.05, each group compared with MEBO control group.
[0206] like Figure 3 As shown,
[0207] In the model control group, the skin wound was not completely healed, with necrosis and inflammatory cell infiltration in the epidermis and superficial dermis, and granulation tissue was visible in the superficial dermis; scabs formed by exudate were visible on the surface, and the epidermal necrotic layer was attached.
[0208] The skin wound of the control group of MEBO was not completely healed, and was partially covered with new epidermis. Granulation tissue was visible in the superficial dermis. Crusts formed by exudate were visible on the surface, and the necrotic layer of the epidermis was attached.
[0209] Among the other groups, the skin healing was best in Group 3 of Experimental Example. Specifically, the skin wound was completely covered by new epidermis, granulation tissue was visible in the superficial dermis, scabs formed by exudate were visible on the surface, and the necrotic layer of the epidermis was attached.
[0210] According to the results in Table 9, we can see that:
[0211] The granulation tissue scores of all test cases and control groups were significantly higher than those of the model control group (P<0.01), and the granulation tissue scores of test case 3 and control group 1 were significantly higher than those of the moist burn ointment control group (P<0.05); the epithelial regeneration scores of test cases 3, 5, 6, 7, and 10 showed an increasing trend compared with the model control group (P>0.05); the neutrophil scores of test cases 3, 5, 6, and 7 showed a decreasing trend compared with the model control group (P>0.05);
[0212] Based on the above experimental results, the conclusions are as follows:
[0213] The results of naked eye observation showed that Test Example 6, Test Example 9 and MEBO were more effective in reducing the wound area.
[0214] The results of histopathological examination showed that the epithelial regeneration indexes in groups 3, 7, 6, 5, and 10 showed a more obvious improvement trend; the granulation tissue score effect in groups 1, 3, and 8 was more obvious than that in other groups; the neutrophil count in groups 3, 5, 6, and 7 showed a more obvious trend of decrease. Based on the results of pathological examination, groups 3, 5, 6, and 7 all had a certain effect on deep wound healing.
[0215] Based on the macroscopic observation and histopathological results, groups 3, 5, 6, and 7 of Experimental Examples all had certain effects on the repair of burn-induced wounds. Among them, group 7 of Experimental Example had a more obvious improvement effect on various indices of deep wound repair; group 3 of Experimental Example had a more prominent effect on deep wound repair; and group 6 of Experimental Example had better wound repair effects than the control group of the moist burn ointment in all indices.
[0216] In addition, the comparative example 1 group and the test example 8 group only had high scores for granulation tissue, indicating that they had certain anti-inflammatory effects, but had no effects on the surface repair and deep repair of the wound; the test example 9 group only had a significant improvement on the wound repair surface, had no effect on the deep repair, and had basically no anti-inflammatory effect; the test example 10 group had a certain deep repair effect, but the effect was not outstanding, and had basically no effect on surface repair and anti-inflammatory.
[0217] Example 3
[0218] This embodiment also provides some Chinese medicine compositions and preparation methods thereof:
[0219] Test Example 11
[0220] Chinese medicine composition: 60g of Lithospermum officinale, 60g of Forsythia suspensa, 40g of Honeysuckle Flos, 40g of Taraxacum mongolicum, 40g of Phellodendron chinense, 2.4g of Scolopendra subspinipes, and 15g of Borneol.
[0221] The preparation method of the Chinese medicine composition comprises the following steps:
[0222] (1) According to the prescribed amount, lithospermum officinale was soaked in 60% ethanol for 20 minutes, with a solid-liquid ratio of 1:8, and heated and extracted twice at 70°C, each time for 2 hours, the extract was filtered, the filtrate was concentrated under reduced pressure at 60°C until there was no alcohol taste, and the clear paste was dried under reduced pressure at 70°C to prepare lithospermum officinale extract;
[0223] (2) Forsythia suspensa, honeysuckle, dandelion, phellodendron chinense and centipede are soaked in water for 0.5 hours, with a solid-liquid ratio of 1:6, and heated and extracted at 75°C for 2 times, each time for 3 hours. The extract is filtered, and the filtrate is concentrated under reduced pressure at 60°C to 8 times to prepare a clear paste. Ethanol is added to make the alcohol content reach 60%, and the filtrate is filtered after standing for 24 hours. The filtrate is concentrated under reduced pressure at 60°C until there is no alcohol taste, filtered, and the clear paste is dried under reduced pressure at 70°C to prepare a dry paste powder;
[0224] (3) crushing borneol into powder, and mixing it with the lithospermum officinale extract in step (1) and the dry paste powder in step (2) to obtain powder;
[0225] (4) Take 200 g of lanolin and 100 g of polyethylene glycol 6000, melt them at 70° C., add the powder obtained in step (3) and mix well. After all the lanolin is dissolved, cool to room temperature to obtain a Chinese medicine composition.
[0226] Test Example 12
[0227] Chinese medicine composition: 60g of Lithospermum officinale, 60g of Forsythia suspensa, 40g of Honeysuckle Flos, 40g of Taraxacum mongolicum, 40g of Phellodendron chinense, 2.4g of Scolopendra subspinipes, and 15g of Borneol.
[0228] The preparation method of the Chinese medicine composition comprises the following steps:
[0229] (1) According to the prescription amount, 80% ethanol was added to the lithospermum officinale and soaked for 40 minutes, with a solid-liquid ratio of 1:14, and heated to reflux for 3 times at 90°C, with each reflux time of 0.5 hour. The extract was filtered, and the filtrate was concentrated under reduced pressure at 80°C until there was no alcohol taste. The clear paste was dried under reduced pressure at 80°C to prepare the lithospermum officinale extract;
[0230] (2) Forsythia suspensa, honeysuckle, dandelion, Phellodendron chinense and Scolopendra subspinipes were soaked in water for 1.5 hours, with a solid-liquid ratio of 1:10, and heated under reflux at 100°C for 3 times, each time for 0.5 hours. The extract was filtered, and the filtrate was concentrated under reduced pressure at 80°C to 8 times to prepare a clear paste. Ethanol was added to make the alcohol content reach 80%, and the mixture was allowed to stand for 72 hours and then filtered. The filtrate was concentrated under reduced pressure at 80°C until there was no alcohol taste, filtered, and the clear paste was dried under reduced pressure at 80°C to prepare a dry paste powder;
[0231] (3) crushing borneol into fine powder, and mixing it with the lithospermum officinale extract in step (1) and the dry paste powder in step (2) to obtain a powder;
[0232] (4) Take 200 g of lanolin and 100 g of polyethylene glycol 6000, melt them at 90° C., add the powder obtained in step (3) and mix well. After all the lanolin is dissolved, cool to room temperature to obtain a Chinese medicine composition.
[0233] Test Example 13
[0234] Chinese medicine composition: 60g of Lithospermum officinale, 60g of Forsythia suspensa, 40g of Honeysuckle Flos, 40g of Taraxacum mongolicum, 40g of Phellodendron chinense, 2.4g of Scolopendra subspinipes, and 15g of Borneol.
[0235] The preparation method of the Chinese medicine composition comprises the following steps:
[0236] (1) According to the prescribed amount, lithospermum officinale and sesame oil were soaked for 20 minutes, with a solid-liquid ratio of 1:5, heated to 160° C., extracted for 5 minutes, and filtered to obtain lithospermum officinale extract;
[0237] (2) Forsythia suspensa, honeysuckle, dandelion, Phellodendron chinense and Scolopendra subspinipes were soaked in water for 0.5 hours with a solid-liquid ratio of 1:6, and heated and extracted twice at 75°C, each time for 3 hours. The extract was filtered, and the filtrate was concentrated to a clear paste with a relative density of about 1.06 (60°C). Ethanol was added to make the alcohol content reach 60%, and the mixture was allowed to stand for 48 hours. The mixture was filtered, and the ethanol was recovered until there was no alcohol taste to obtain a concentrated solution;
[0238] (3) Take borneol and crush it into powder;
[0239] (4) Take 200g of lanolin and 15g of stearic acid glyceryl, heat them to 70°C, and add lithospermum extract after they are completely melted, and mix them to obtain the oil phase; take 100g of polyethylene glycol 6000 and 50g of Tween 80, heat them to 70°C, and add the concentrate after they are completely melted to obtain the water phase; at 70°C, slowly add the water phase to the oil phase, stir, cool, add borneol powder, and stir evenly to obtain the Chinese medicine composition.
[0240] Test Example 14
[0241] Chinese medicine composition: 60g of Lithospermum officinale, 60g of Forsythia suspensa, 40g of Honeysuckle Flos, 40g of Taraxacum mongolicum, 40g of Phellodendron chinense, 2.4g of Scolopendra subspinipes, and 15g of Borneol.
[0242] The preparation method of the Chinese medicine composition comprises the following steps:
[0243] (1) According to the prescribed amount, lithospermum officinale and sesame oil were soaked for 40 minutes, with a solid-liquid ratio of 1:8, heated to 140° C., extracted for 20 minutes, and filtered to obtain lithospermum officinale extract;
[0244] (2) Forsythia suspensa, honeysuckle, dandelion, Phellodendron chinense and Scolopendra subspinipes were soaked in water for 1.5 hours with a solid-liquid ratio of 1:10, and heated under reflux for 3 times at 100°C, each time for 0.5 hours. The extract was filtered, and the filtrate was concentrated to a clear paste with a relative density of about 1.10 (60°C). Ethanol was added to make the alcohol content reach 80%, and the mixture was allowed to stand for 72 hours. The mixture was filtered, and the ethanol was recovered until there was no alcohol taste to obtain a concentrated solution;
[0245] (3) Take borneol and crush it into fine powder;
[0246] (4) Take 200g of lanolin and 15g of stearic acid glyceryl, heat them to 90°C, and add lithospermum extract after they are completely melted, and mix them to obtain the oil phase; take 100g of polyethylene glycol 6000 and 50g of Tween 80, heat them to 90°C, and add the concentrate after they are completely melted to obtain the water phase; at 90°C, slowly add the water phase to the oil phase, stir, cool, add borneol powder, and stir evenly to obtain the Chinese medicine composition.
[0247] The above description of the embodiments is to facilitate the understanding and use of the invention by those skilled in the art. It is obvious that those skilled in the art can easily make various modifications to these embodiments and apply the general principles described herein to other embodiments without creative work. Therefore, the present invention is not limited to the above embodiments, and improvements and modifications made by those skilled in the art based on the disclosure of the present invention without departing from the scope of the present invention should be within the scope of protection of the present invention.
Claims
1. A Chinese medicine composition for promoting wound healing or repairing skin damage, characterized in that: The traditional Chinese medicine composition comprises, by weight, 35-80 parts of lithospermum officinale, 35-80 parts of forsythia, 15-60 parts of honeysuckle, 15-60 parts of dandelion, 15-60 parts of phellodendron, 0.5-4 parts of centipede and 1-30 parts of borneol.
2. The Chinese medicine composition according to claim 1, characterized in that: The traditional Chinese medicine composition comprises, by weight, 40-70 parts of lithospermum officinale, 40-70 parts of forsythia, 20-50 parts of honeysuckle, 20-50 parts of dandelion, 20-50 parts of phellodendron, 1-4 parts of centipede and 5-30 parts of borneol.
3. A method for preparing the Chinese medicine composition according to claim 1 or 2, characterized in that: The method comprises the following steps: Step 1, soaking Lithospermum officinale with a first extractant, heating and extracting, to obtain a first extract; the first extractant is alcohol or oil; Step 2, soaking the forsythia, honeysuckle, dandelion, phellodendron, and centipede in a second extractant, heating and extracting, and obtaining a second extract; Step 3: Crush the borneol to obtain borneol powder, and mix the borneol powder with the first extract and the second extract to obtain a traditional Chinese medicine composition.
4. The preparation method according to claim 3, characterized in that: The oil is sesame oil; preferably, the solid-liquid ratio of the lithospermum officinale to the sesame oil is 1:(5-8); preferably, the soaking time is 20-40 minutes; preferably, the heating extraction temperature is 140°C-160°C, and the heating time is 5-20 minutes.
5. The preparation method according to claim 3, characterized in that: The alcohol is ethanol; preferably, the concentration of the ethanol is 60%-80%; preferably, in the step 1, ethanol is used to soak the lithospermum for 20-40 minutes; more preferably, the solid-liquid ratio of lithospermum to ethanol in the step 1 is 1:(8-14); more preferably, the solid-liquid ratio of lithospermum to ethanol in the step 1 is 1:(10-12); Preferably, the heating extraction is heating reflux; more preferably, in the step 1, the first extractant is used as the heating reflux extractant and the heating reflux is performed 2-3 times, each time for 0.5-2 hours.
6. The preparation method according to claim 3, characterized in that: The second extractant is water; preferably, the soaking time of Forsythia suspensa, honeysuckle, dandelion, Phellodendron chinense, and Scolopendra subspinipes in the second extractant in the step 2 is 0.5-1.5 hours; preferably, the solid-liquid ratio of Forsythia suspensa, honeysuckle, dandelion, Phellodendron chinense, and Scolopendra subspinipes to water in the step 1 is 1:(6-10); Preferably, the heating extraction in step 2 is performed by heating and reflux with the second extractant as the extractant for 2-3 times, each time for 0.5-3 hours.
7. The preparation method according to claim 3, characterized in that: The step 2 also includes an alcohol precipitation step, wherein the alcohol precipitation is to combine the extracts after heating and refluxing and concentrate them into a clear paste, and ethanol is added to the clear paste to make the alcohol content reach 60%-80%; more preferably, 70%.
8. A product comprising the Chinese medicine composition as claimed in claim 1 or 2; preferably, the product is in the form of an ointment.
9. Use of the Chinese medicine composition according to claim 1 or 2, or the preparation method according to any one of claims 3 to 7, or the product according to claim 8 in preparing a drug for promoting wound healing or a drug for repairing skin damage.
10. Use of the Chinese medicine composition according to claim 1 or 2, the preparation method according to any one of claims 3 to 7, or the product according to claim 8 in preparing a medicine for treating burns.
Citation Information
Patent Citations
Pharmaceutical composition for accelerating wound healing and removing scars and application thereof
CN116251143A
Chinese medicine preparation for sore, ulcer and infection caused by external wound and preparation method
CN1169863A
Ointment for treating burn and its preparing process
CN1730049A
